These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1281430)

  • 1. The interaction of a glycosaminoglycan, heparin, with HIV-1 major envelope glycoprotein.
    Mbemba E; Czyrski JA; Gattegno L
    Biochim Biophys Acta; 1992 Dec; 1180(2):123-9. PubMed ID: 1281430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
    Haidar M; Seddiki N; Gluckman JC; Gattegno L
    Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate.
    Mbemba E; Chams V; Gluckman JC; Klatzmann D; Gattegno L
    Biochim Biophys Acta; 1992 Jan; 1138(1):62-7. PubMed ID: 1371075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.
    Rabehi L; Ferriere F; Saffar L; Gattegno L
    Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
    Abacioglu YH; Fouts TR; Laman JD; Claassen E; Pincus SH; Moore JP; Roby CA; Kamin-Lewis R; Lewis GK
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):371-81. PubMed ID: 8068416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of HIV-1 and HIV-2 envelope glycoproteins with sulphated polysaccharides and mannose-6-phosphate.
    Mbemba E; Gluckman JC; Gattegno L
    Glycobiology; 1994 Feb; 4(1):13-21. PubMed ID: 8186546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
    Su H; Boackle RJ
    Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
    Gorse GJ; Corey L; Patel GB; Mandava M; Hsieh RH; Matthews TJ; Walker MC; McElrath MJ; Berman PW; Eibl MM; Belshe RB
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):115-32. PubMed ID: 10029244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of HIV-1 envelope glycoproteins with derivatized dextrans.
    Carré V; Mbemba E; Letourneur D; Jozefonvicz J; Gattegno L
    Biochim Biophys Acta; 1995 Feb; 1243(2):175-80. PubMed ID: 7532999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by gp160 glycoprotein of HIV-1.
    Thieblemont N; Haeffner-Cavaillon N; Weiss L; Maillet F; Kazatchkine MD
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):229-33. PubMed ID: 8471312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
    Lederman S; Gulick R; Chess L
    J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
    Fenouillet E; Gluckman JC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoproliferative responses to mitogens and HIV-1 envelope glycoprotein among volunteers vaccinated with recombinant gp160.
    Tacket CO; Baqar S; Munoz C; Murphy JR
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):535-42. PubMed ID: 2187503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4.
    Andersen O; Sørensen AM; Svehag SE; Fenouillet E
    Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
    Harrop HA; Rider CC
    Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.
    Cooney EL; McElrath MJ; Corey L; Hu SL; Collier AC; Arditti D; Hoffman M; Coombs RW; Smith GE; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1882-6. PubMed ID: 8446603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The envelope of HIV-1 as a key component to infectivity.
    Buchbinder A
    Prog AIDS Pathol; 1990; 2():1-11. PubMed ID: 2103853
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenic and antigenic properties of an HIV-1 gp120-derived multiple chain peptide.
    Kelker HC; Schlesinger D; Valentine FT
    J Immunol; 1994 Apr; 152(8):4139-48. PubMed ID: 8144976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
    Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
    AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.